A Comparative Study of Cancer Burden Among Males Aged 35 to 75 years in Ghana: Evidence from GLOBOCAN 2022

Authors

DOI:

https://doi.org/10.15503/emet2024.77.89

Keywords:

GLOBOCAN 2022, Ghana, liver cancers, male cancers, cancer

Abstract

Background Cancer is a leading cause of death globally, ranking second behind cardi- ovascular diseases as the all-time leading cause of death in the world. In Ghana, there was an increased rise in cancer cases from 24,009 in 2020 to 27,385 in 2022. The total number of deaths due to cancer in 2020 in Ghana was 15,802, which rose to a total mortality of 17,944. Liver cancer is the most common form of cancer among Ghanaian males, which is followed by prostate cancer. However, among Ghanaian men aged 55+ years, prostate cancer is the leading cancer incidence.

Aim The study aimed to examine the cancer burden among Ghanaian males aged 35 to 75+ years using the GLOBOCAN 2022 cancer estimates.

Materials and Methods The incidence and mortality cases, as well as the age-stand- ardised incidence and mortality ratios on the various forms of cancer among Ghanaian males aged 35 to 75+ years, were obtained from the GLOBOCAN 2022 cancer estimates.

Results A total of 11,398 cancer cases were recorded in 2022 among Ghanaian males. Liver cancer constituted 23.3% of the total cancer cases, and the incidence of prostate cancer in Ghana was 2,395 (21.0%). The leading age-specific incidence and mortality rate of cancer among Ghanaian males aged 35 to 44 years was liver cancer disease, with age- standardised incidence of 35 per 100,000. Even though prostate cancer was the highest cancer incidence among men aged 55 to 64 years in Ghana, liver cancer was observed to have the most mortality cases with an age- standardised mortality ratio of 50 per 100,000.

Conclusion The leading cause of cancer incidence among Ghanaian males was liver cancer. However, prostate cancer was most common among men aged above 54 years. Lifestyle changes, infiltration of national tobacco and alcoholic companies, late detection and screening, lack of knowledge and awareness, and limited health system are chal- lenges faced by the prevention and control of cancer cases among Ghanaian males.

Downloads

Download data is not yet available.

References

Altamirano, J., & Bataller, R. (2008). Cigarette smoking and chronic liver diseases.

Amoako, Y. A., Awuah, B., Larsen-reindorf, R., Awittor, F. K., Kyem, G., Ofori-boadu, K., Osei- Bonsu E., Odai Laryea D. (2019). Malignant tumours in urban Ghana: Evidence from the city of

Kumasi. BMC Cancer, 19(1).

Clark, R., Vesprini, D., & Narod, S. A. (2022). The effect of age on prostate cancer survival.

Cancers (Basel), 14(17). 1–12.

Dalinjong, P. A., Welaga, P., Azongo, D. K., Chatio, S., Anaseba, D., Kondayire, F., Akazili J., Deb-

puur C., Oduro A. (2015). A retrospective analysis of the association between tobacco smoking and deaths from respiratory and cardiovascular diseases in the Kassena-Nankana districts of Northern Ghana. Tobacco Induced Diseases, 13(1). 1–9.

Doku, D., Darteh, E. K. M., & Kumi-Kyereme, A. (2013). Socioeconomic inequalities in cigarette smoking among men: Evidence from the 2003 and 2008 Ghana demographic and health surveys. Archives of Public Health, 71(1). 3–9.

Drummond, F. J., Reidy, M., von Wagner, C., & Livingstone, V. (2019). Health literacy influences men’s active and passive cancer information seeking. Health Literacy Research and Practice, 3(3). Duah, A., & Nartey, Y. A. (2023). Clinical profile and limitations in the management of HBV patients

attending clinic at a district hospital in Ghana. International Journal of Hepatology, 2023.

Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., Bray F., (2021).

Cancer statistics for the year 2020: An overview. International Journal of Cancer, 149(4). 778–789. Ferlay, J., Rebecca, M. E., & Mph, L. S. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. [Forthcoming or in-press

details], (February), 1–35.

Fujita, K., & Nonomura, N. (2019). Role of androgen receptor in prostate cancer: A review. World

Journal of Men’s Health, 37(3). 288–295.

Ganne-Carrié, N., & Nahon, P. (2019). Hepatocellular carcinoma in the setting of alcohol-related

liver disease. Journal of Hepatology, 70, 243–255. [Exact page range if available]

Ghana Statistical Service. (2015). Ghana Demographic and Health Survey 2014. Ghana Statistical Ser- vice, Accra, Ghana & ICF. Retrieved from https://dhsprogram.com/pubs/pdf/sr224/sr224.pdf. Guo, C., Liu, Z., Lin, C., Fan, H., Zhang, X., Wang, H., Han X., Li Y., Mu L., Yu S., Zhang T., (2023). Global epidemiology of early-onset liver cancer attributable to specific aetiologies and risk factors

from 2010 to 2019. Journal of Global Health, 13. 1–10.

Guo, C. C., & Czerniak, B. (2023). Updates of prostate cancer from the 2022 World Health Organi-

zation classification of the urinary and male genital tumors. Journal of Clinical and Translational

Pathology, 000, 000–000. doi: 10.14218/JCTP.2022.00029.

Id, J. A., Chen, Y., Wang, H., Sompo, F. M., Wu, I. X. Y., ... et al. (2020). Prevalence of viral hepati-

tis B in Ghana between 2015 and 2019: A systematic review and meta-analysis. PLoS ONE, 15,

e0234348.

Kaninjing, E., Lopez, I., Nguyen, J., Odedina, F., & Young, M. E. (2018). Prostate cancer screening

perception, beliefs, and practices among men in Bamenda, Cameroon. American Journal of Men’s

Health, 12(5). 1463–1472.

Laryea, D. O., Awuah, B., Amoako, Y. A., Osei-Bonsu, E., Dogbe, J., Larsen-Reindorf, R., ... et al.

(2014). Cancer incidence in Ghana, 2012: Evidence from a population-based cancer registry. BMC

Cancer, 14(1). 1–8.

Macrotrends. (2024). World population statistics. Retrieved from https://www.macrotrends.net/

global- metrics/countries/population-growth-rate/.

Mensah, K. B., Bemah, A., Mensah, B., Yamoah, P., Attakorah, J., Bangalee, V., Oosthuizen F. (2022).

Knowledge assessment and barriers to cancer screening among Ghanaian community pharma-

cists. Journal of Oncology Pharmacy Practice, 28(1). 64-73.

Miranville, A. (2021). Annual report 2020. AIMS Mathematics, 6(12), 14064–14068.

Mohammed, H. (2022). Prevalence of hepatitis B virus and associated risk factors among adult

patients at Dessie referral and Kemise general hospitals in northeastern Ethiopia. Health Science

Reports, 5(3).

National Cancer Institute (NIH). (2021). Age and cancer risk. Retrieved from https://www.cancer.

gov/about- cancer/causes-prevention/risk/age.

Necku, J. G., Anaba, E. A., & Abuosi, A. A. (2019). Prostate cancer awareness and attitude toward

early detection among male soldiers in Ghana: A cross-sectional study. African Journal of Urology,

(1). 3–8. doi: 10.1186/s12301-019-0004-3.

Ntekim, A., Folasire, A., & Odukoya, O. A. (2023). The prevalence of prostate cancer among young

men below 55 years of age in Nigeria. Cancer Control, 30. 1–7.

Opare-Asamoah, K., Majeed, S. F., Owusu, A. O., Okyere, K., Owusu, E. A., Wondoh, P. M., Kunfah

S. M., Fosu E. S., Yorke J., Yakong V. N., Tabiri S. (2021). The prevalence and risk factors of hepa- titis B virus infection among dwellers in a peri-urban district of Ghana: A cross-sectional study. Journal of Medical and Biomedical Sciences, 8 (2), 12–20.

Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., Laversanne M., McGlynn K. A., Soerjomataram I. (2022). Global burden of primary liver cancer in 2020 and predictions to 2040. Journal of Hepatology, 77(6). 1598–1606.

Rutledge, S. M., & Asgharpour, A. (2020). Smoking and liver disease. Gastroenterology & Hepatology, 16(12). 617–625.

Shao, M., Wang, Y., Dong, H., Wang, L., Zhang, X., Han, X., Sang X., Bao Y., Peng M., Cao G. (2023). From liver fibrosis to hepatocarcinogenesis: Role of excessive liver H2O2 and targeting nano- therapeutics. Bioactive Materials, 23, 187–205. doi: 10.1016/j.bioactmat.2022.11.001.

Shi, Y., Han, J. J., Tennakoon, J. B., Mehta, F. F., Merchant, F. A., Burns, A. R., Howe M. K., McDonnel D. P., Frigo D. E. (2013). Androgens promote prostate cancer cell growth through induction of autophagy. Molecular Endocrinology, 27(2). 280–295.

Sowunmi, A., Alabi, A., Fatiregun, O., Olatunji, T., Okoro, U. S., Francis, A. (2018). Trend of cancer incidence in an oncology center in Nigeria. West African Journal of Radiology, 25(1). 52–56.

Tuck, C. Z., Cooper, R., Aryeetey, R., Gray, L. A., & Akparibo, R. (2023). A critical review and analy- sis of the context, current burden, and application of policy to improve cancer equity in Ghana. International Journal for Equity in Health, 2. 1–11.

Turati, F., Galeone, C., Rota, M., & Negri, E. (2014). Alcohol and liver cancer: A systematic review. [Journal/Publisher information if available], (March).

United States Cancer Statistics Data Briefs. (2023). Prostate cancer incidence by stage at diagnosis, United States 2001–2019. [Publisher or URL if available]

Wen, Y. F., Chen, M. X., Yin, G., Lin, R., Zhong, Y. J., Dong, Q. Q., Wong H. M. (2021). The global, regional, and national burden of cancer among adolescents and young adults in 204 countries and territories, 1990–2019: A population-based study. Journal of Hematology & Oncology, 14(1), 1–14. doi: 10.1186/s13045-021-01093-3.

Downloads

Published

2025-07-27

How to Cite

Agyemang, E. A., Gmanyami, J. M., Amoakoh, M. Y., Kwaah, P. A., Lameck, T., Agbor, D. A., Agyemang, E. O., DJanie, S. N., & Amuasi, J. H. (2025). A Comparative Study of Cancer Burden Among Males Aged 35 to 75 years in Ghana: Evidence from GLOBOCAN 2022. E-Methodology, 11(11), 77–89. https://doi.org/10.15503/emet2024.77.89

Issue

Section

“On the Internet” – Research